The loss of TDP-43’s normal function in the nucleus, combined with its toxic gain of function in the cytoplasm, may contribute to the mechanisms underlying TDP-43 proteinopathy (Scotter et al., 2015; Arseni et al., 2022). This evidence concerns the gene TARDBP and proteostasis deficiencies.